Grozescu T, Popa F. Immunotherapy and gene therapy in prostate cancer treatment.
J Med Life 2017;
10:54-55. [PMID:
28255378 PMCID:
PMC5304374]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2016] [Accepted: 10/05/2016] [Indexed: 10/25/2022] Open
Abstract
There are few methods bringing several relatively recent advances in therapy of certain types of prostate cancer. Belonging to personalized therapies, they use cells (normal or pathologic) from the patient, modify and reintroduce them in the patient's body, leading to an increased efficiency against the neoplastic tissue, proving to increase the patient's lifespan and/ or tumor progression.
Collapse